Frankfurt - Delayed Quote EUR

Towa Pharmaceutical Co., Ltd. (6QC.F)

18.10
+0.30
+(1.69%)
At close: May 23 at 8:03:59 AM GMT+2

Research Analysis

Revenue vs. Earnings

Revenue 65.86B
Earnings --

Q2'24

Q3'24

Q4'24

Q1'25

0
20B
40B
60B
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2026)Next Year (2027)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in JPY Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2026)Next Year (2027)
No. of Analysts 2145
Avg. Estimate 66.66B65.6B277.46B293.62B
Low Estimate 66.51B65.6B272.5B279.41B
High Estimate 66.8B65.6B281B307B
Year Ago Sales 62.57B60.84B172.27B277.46B
Sales Growth (year/est) 6.54%7.83%61.06%5.83%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2026)Next Year (2027)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2026)Next Year (2027)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
6QC.F --------
S&P 500 12.65%2.49%7.39%14.05%